Search Results 21-30 of 35089 for chemoprevention
The purpose of this study is to determine whether COX-2 enzyme activity in pancreatic cystic neoplasms is sufficient to justify a chemoprevention study.
Niloy Jewel J. Samadder, M.D., studies the genetic and molecular epidemiology of hereditary cancer syndromes and chemoprevention in hereditary colorectal ...
... chemopreventive regimens. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...
... chemoprevention or chemotherapy of prostate cancer. Lastly, through ... chemopreventive effects on prostate cancer. In vitro and in vivo systems are ...
... chemoprevention, immunoprevention, targeted ablation and innovative agent delivery methods. Program leadership. Ajit H. Goenka, M.D.. Dr. Goenka is a ...
To help you manage your risk, Mayo Clinic specialists offer the latest breast cancer surgery techniques and options for breast cancer chemoprevention.
... chemoprevention, or even prophylactic mastectomies. The findings suggest that both breast density and common genetic variation are important for risk ...
The study will determine breast density (MMG) and correlate with qLI. The study will also determine the influence of chemoprevention therapies such as tamoxifen ...
The plans offer options that might include additional screening, breast cancer chemoprevention and preventive surgeries, such as prophylactic mastectomy and ...
The purpose of this study is to determine whether COX-2 enzyme activity in pancreatic cystic neoplasms is sufficient to justify a chemoprevention study. A ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.